Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004583566 | SCV005065950 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7; Autosomal recessive limb-girdle muscular dystrophy type 2U | 2023-03-24 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the ISPD protein in which other variant(s) (p.Val372del) have been determined to be pathogenic (PMID: 23288328, 23390185, 27234031, 31127727). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with ISPD-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 4-8 of the ISPD gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. |